Trial · NCT03008889
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Randomized | Participants Taking NAC | 100 | percentage of participants randomized | ||
| Percentage of Participants Randomized | Participants Taking Placebo | 100 | percentage of participants randomized | ||
| Attrition Rate | Participants Taking NAC | 0 | percentage of participants | ||
| Attrition Rate | Participants Taking Placebo | 0 | percentage of participants | ||
| Study Medication Compliance | Participants Taking NAC | 1 | Participants | ||
| Study Medication Compliance | Participants Taking Placebo | 1 | Participants | ||
| Successful Collection of Outcome Measures | Participants Taking NAC | 1 | Participants | ||
| Successful Collection of Outcome Measures | Participants Taking Placebo | 1 | Participants | ||
| Parent Satisfaction Rating | Participants Taking NAC | 1 | Participants | ||
| Parent Satisfaction Rating | Participants Taking Placebo | 1 | Participants | ||
| Positive Predictive Value of Screening Method of Classifying Self-injurious Behavior (SIB) by Type. | Consented Participants Before Randomization | 3 | Participants | ||
| Aberrant Behavior Checklist Irritability Subscale Score at Baseline and 9 Weeks Post-intervention | Participants Taking NAC | Score at Baseline | 31 | score on a scale | |
| Aberrant Behavior Checklist Irritability Subscale Score at Baseline and 9 Weeks Post-intervention | Participants Taking Placebo | Score at Baseline | 28 | score on a scale | |
| Aberrant Behavior Checklist Irritability Subscale Score at Baseline and 9 Weeks Post-intervention | Participants Taking NAC | Score at 9-Weeks | 23 | score on a scale | |
| Aberrant Behavior Checklist Irritability Subscale Score at Baseline and 9 Weeks Post-intervention | Participants Taking Placebo | Score at 9-Weeks | 29 | score on a scale | |
| Number of Self-Injurious Behavior Events | Participants Taking NAC | Baseline | 219 | Self injurious events | |
| Number of Self-Injurious Behavior Events | Participants Taking Placebo | Baseline | 93 | Self injurious events | |
| Number of Self-Injurious Behavior Events | Participants Taking NAC | 9-Weeks | 59 | Self injurious events | |
| Number of Self-Injurious Behavior Events | Participants Taking Placebo | 9-Weeks | 655 | Self injurious events | |
| Change in Clinical Global Impression (CGI-I) Scale at 9 Weeks Post-intervention | Participants Taking NAC | 2 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03008889/results